KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Long-Term Investments (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Long-Term Investments for 6 consecutive years, with $187.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments fell 7.25% year-over-year to $187.1 million, compared with a TTM value of $187.1 million through Dec 2025, down 7.25%, and an annual FY2025 reading of $187.1 million, down 7.25% over the prior year.
  • Long-Term Investments was $187.1 million for Q4 2025 at Clover Health Investments, up from $12.4 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $310.5 million in Q3 2023 and bottomed at $390000.0 in Q2 2021.
  • Average Long-Term Investments over 5 years is $120.8 million, with a median of $103.0 million recorded in 2024.
  • The sharpest move saw Long-Term Investments soared 67271.03% in 2022, then plummeted 98.48% in 2023.
  • Year by year, Long-Term Investments stood at $146.2 million in 2021, then fell by 6.03% to $137.4 million in 2022, then surged by 68.14% to $231.0 million in 2023, then fell by 12.67% to $201.7 million in 2024, then dropped by 7.25% to $187.1 million in 2025.
  • Business Quant data shows Long-Term Investments for CLOV at $187.1 million in Q4 2025, $12.4 million in Q3 2025, and $12.5 million in Q2 2025.